In vivo effects of noradrenaline and noradrenergic receptor agonists and antagonists on rat cerebellar cyclic GMP levels
- 1 May 1980
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 63 (4) , 287-294
- https://doi.org/10.1016/0014-2999(80)90257-5
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effect of L-glutamate and kainate on rat cerebellar cGMP levels in vivoEuropean Journal of Pharmacology, 1979
- Climbing fiber activation and 3′,5′-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellumBrain Research, 1976
- Effects of stress on mouse brain cyclic nucleotide levels in vivoBrain Research, 1975
- Evidence for a central α-sympathomimetic action of Clonidine in the ratJournal of Pharmacy and Pharmacology, 1975
- Effects of arecoline and cholinesterase inhibitors on cyclic guanosine 3?,5?-monophosphate and adenosine 3?,5?-monophosphate in mouse brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975
- ELEVATION OF CYCLIC GMP LEVELS IN CENTRAL NERVOUS SYSTEM BY EXCITATORY AND INHIBITORY AMINO ACIDS1Journal of Neurochemistry, 1974
- Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellumBiochemical and Biophysical Research Communications, 1972
- Pharmacological studies on the hypotensive effects of clonidineEuropean Journal of Pharmacology, 1971
- The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellumBiochemical and Biophysical Research Communications, 1970
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968